Clinical Trials

Alliance for Clinical Trials in Oncology

https://www.allianceforclinicaltrialsinoncology.org/

23-025

A011801-The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib

UNDER CONSIDERATION/ In-START-UP: Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Key Contacts

Cookie Disclaimer: By using or otherwise accessing the website, you agree to that this website uses cookies and similar technologies, including those provided by vendors, for various purposes, such as to support website performance, features, and analytics (for example, Google Analytics). These cookies may process data such as IP addresses, including for them to function properly. Cookie vary across the website, including per webpage. For more information, see the Website Privacy Policy. Use or other access to this website is subject to the Website Terms and Conditions.

Alliance for Clinical Trials in Oncology

Resources

Key Contacts